BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 10929504)

  • 1. [Antimicrobial resistance characteristics of clinical isolates of Streptococcus pyogenes].
    Rodríguez RS; Calderón-Jaimes E; Gómez-Barreto D; Espinosa-de los Monteros LE
    Salud Publica Mex; 2000; 42(3):226-9. PubMed ID: 10929504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Differentiation of resistance phenotypes among erythromycin-resistant streptococci].
    Bejuk D
    Acta Med Croatica; 2004; 58(4):301-6. PubMed ID: 15700686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High macrolide resistance in Streptococcus pyogenes strains isolated from children with pharyngitis in China.
    Liu X; Shen X; Chang H; Huang G; Fu Z; Zheng Y; Wang L; Li C; Liu L; Shen Y; Yang Y
    Pediatr Pulmonol; 2009 May; 44(5):436-41. PubMed ID: 19360846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Susceptibility of Streptococcus pyogenes to macrolides and quinolones in Guadalajara, Spain].
    Rodríguez-Zurita ME; Solís del Baño S; Robres Guillén P; González Praetorius A; Gimeno Fernández C; Pérez Pomata MT; Bisquert Santiago J
    Rev Esp Quimioter; 2003 Mar; 16(1):61-4. PubMed ID: 12750759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macrolide-resistant Streptococcus pyogenes in the United States, 2002-2003.
    Richter SS; Heilmann KP; Beekmann SE; Miller NJ; Miller AL; Rice CL; Doern CD; Reid SD; Doern GV
    Clin Infect Dis; 2005 Sep; 41(5):599-608. PubMed ID: 16080080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Emergence of resistance to macrolides in Streptococcus pyogenes].
    Vinagre C; Cifuentes M; Valdivieso F; Ojeda A; Prado V
    Rev Med Chil; 1999 Dec; 127(12):1447-52. PubMed ID: 10835751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Phenotypes of macrolide, lincosamide, and streptogramin resistant Streptococcus viridans isolated from blood].
    Rodríguez-Avial C; García MM; Rodríguez-Avial I; Picazo JJ
    Rev Esp Quimioter; 1999 Dec; 12(4):346-51. PubMed ID: 10855014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Streptococcus pyogenes: penicillin and erythromycin susceptibility in the cities of Neuquen and Cipolletti].
    Soriano SV; Brasili S; Saiz M; Carranza C; Vidal P; Calderón J; Lopardo HA
    Medicina (B Aires); 2000; 60(4):487-90. PubMed ID: 11188957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A rapid increase in macrolide resistance in Streptococcus pyogenes isolated in Poland during 1996-2002.
    Szczypa K; Sadowy E; Izdebski R; Hryniewicz W
    J Antimicrob Chemother; 2004 Oct; 54(4):828-31. PubMed ID: 15329367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the degree of susceptibility of Streptococcus pyogenes erythromycin-resistant strains to rokitamycin (a 16-membered macrolide) using the Epsilometer test.
    Crotti D; Rossetti R; Braga PC
    Drugs Exp Clin Res; 2004; 30(1):17-26. PubMed ID: 15134387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Macrolide antibiotic resistance rates and phenotypes of group A beta hemolytic streptococci isolated between the years 1999-2000 and 2001-2002].
    Senses Z; Baysallar M; Gür D; Doğanci L
    Mikrobiyol Bul; 2003 Oct; 37(4):225-34. PubMed ID: 14748258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial susceptibility patterns and macrolide resistance genes of beta-hemolytic streptococci in Korea.
    Uh Y; Jang IH; Hwang GY; Lee MK; Yoon KJ; Kim HY
    Antimicrob Agents Chemother; 2004 Jul; 48(7):2716-8. PubMed ID: 15215133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and mechanisms of macrolide resistance in Streptococcus pyogenes in Ankara, Turkey.
    Colakoglu S; Alacam R; Hascelik G
    Scand J Infect Dis; 2006; 38(6-7):456-9. PubMed ID: 16798693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macrolide resistance among middle ear isolates of Streptococcus pneumoniae observed at eight United States pediatric centers: prevalence of M and MLSB phenotypes.
    Mason EO; Wald ER; Bradley JS; Barson WJ; Kaplan SL;
    Pediatr Infect Dis J; 2003 Jul; 22(7):623-7. PubMed ID: 12867838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Emergence of macrolide resistant Streptococcus pyogenes strains in pediatric patients in France].
    Mariani-Kurkdjian P; Doit C; Deforche D; Brahimi N; Francois M; Van den Abbeele T; Bingen E
    Pathol Biol (Paris); 2004 Oct; 52(8):489-92. PubMed ID: 15465270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Study of antibiotic sensitivity of Streptococcus pyogenes isolated in the hospital milieu (Charles Nicolle hospital of Tunis)].
    el Bour M; Fendri C; Ben Hassen A; Kamoun A; Boudabbous A; Ben Redjeb S
    Med Trop (Mars); 1993; 53(1):13-7. PubMed ID: 8505883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Characterization of macrolide-resistance mediated by transposable elements Tn1545 and Tn917 in clinical Isolates of Streptococcus pneumoniae].
    Wu WJ; Hong XH; Zhang H; Jiang YQ; Lu Q; Ni YX
    Zhonghua Yi Xue Za Zhi; 2006 Mar; 86(9):605-8. PubMed ID: 16681905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Investigation of erythromycin resistance and resistance phenotypes in group A beta hemolytic streptococci].
    Kaya EG; Yücel M; Karakoç AE
    Mikrobiyol Bul; 2006 Jul; 40(3):161-8. PubMed ID: 17001844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial susceptibility and macrolide resistance genes in Streptococcus pyogenes collected in Austria and Hungary.
    Gattringer R; Sauermann R; Lagler H; Stich K; Buxbaum A; Graninger W; Georgopoulos A
    Int J Antimicrob Agents; 2004 Sep; 24(3):290-3. PubMed ID: 15325435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macrolide resistance determinants of group A streptococci in Ankara, Turkey.
    Acikgoz ZC; Gocer S; Tuncer S
    J Antimicrob Chemother; 2003 Jul; 52(1):110-2. PubMed ID: 12805256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.